Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

NCT00059995

Conditions
Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, Hemic and Lymphatic Diseases, +19 more
Locations
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

NCT00006345

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +13 more
Locations
  • Veterans Affairs Medical Center - Miami Miami, Florida, United States
  • Rush Cancer Institute Chicago, Illinois, United States
  • Tulane University School of Medicine New Orleans, Louisiana, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma

NCT00061880

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

NCT00898872

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Piedmont Hospital Atlanta, Georgia, United States
  • Northside Hospital Cancer Center Atlanta, Georgia, United States
  • Saint Joseph's Hospital of Atlanta Atlanta, Georgia, United States
View all 82 locations
View Trial Details
Completed

Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma

NCT00030849

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Abramson Cancer Center of the University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions